Renflexis Prices, Coupons and Patient Assistance Programs
Renflexis (infliximab) is a member of the TNF alfa inhibitors drug class and is commonly used for Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Acute, and others.
Renflexis Prices
This Renflexis price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Renflexis intravenous powder for injection abda 100 mg is around $795 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Intravenous Powder For Injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $795.04 | $795.04 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Renflexis Coupons and Rebates
Renflexis offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Renflexis Merck Co-Pay Assistance Program: Eligible patients pay the 1st $5 per prescription with savings of up to $20,000 per calendar year; for additional information contact the program at 866-847-3539.
| Applies to: | Renflexis |
| Number of uses: | Per prescription until program expires |
| Expires | December 31, 2018 |
Patient Assistance Programs for Renflexis
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- Medically appropriate condition/diagnosis
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Renflexis (infliximab-ABDA)
Provider: Merck Connect
Elligibility requirements:
- Determined case by case
- Not disclosed
- Medically Necessary as determined by a Doctor
- Must be treated by US licensed healthcare provider
- Resources for HEALTHCARE PROFESSIONALS ONLY. The Physician must register to access tools and materials for patient support, product sample requests, up-to-date professional resources, and other Merck professional sites.
Applicable drugs:
- Renflexis (infliximab-ABDA)
Provider: Merck Access Program for Renflexis
Elligibility requirements:
- Determined case by case
- Not disclosed
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Patients in need who appear not to qualify should still call.
Applicable drugs:
- Renflexis (infliximab-ABDA)
More about Renflexis (infliximab)
- Renflexis Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- Drug class: TNF alfa inhibitors
Consumer resources
Other brands: Remicade, Inflectra, Ixifi
